North Carolina may lose pharma project after passing law targeting LGBT community

Two weeks ago North Carolina governor Gov. Pat McCrory was pointing to a proposed project by New Jersey-based Braeburn Pharmaceuticals and bragging about what a great job the state has done attracting pharma companies. But Braeburn is having second thoughts about the state after the governor last week signed a bill that eliminated local protections for gay and transgender people and limits the bathroom choices they have. In a statement to WNCN in Durham, NC, Braeburn called the law "unjust. It is slated to receive up to $275,000 in incentives for the project. "Braeburn Pharmaceuticals believes in fair treatment and equality for all individuals in their communities. We oppose any legislation that discriminates against the LGBT community," the company said. More from FiercePharmaManufacturing

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.